-
Research/Project Funding Opportunity
-
Posted 1 year ago
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
at
Department of Health and Human Services National Institutes of Health
in
États-Unis
0
0
Department of Health and Human Services National Institutes of Health
